HuGE Literature Finder
Records 1-30
|
Next generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Journal of hepatology 2020 Jul . Magaz Marta, Alvarez-Larrán Alberto, Colomer Dolors, López-Guerra Mónica, García-Criado M Ángeles, Mezzano Gabriel, Belmonte Ernest, Olivas Pol, Soy Guillem, Cervantes Francisco, Darnell Anna, Ferrusquía-Acosta José, Baiges Anna, Turon Fanny, Hernández-Gea Virginia, García-Pagán Juan Carl |
|
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
British journal of haematology 2020 Feb . Andréasson Björn, Pettersson Helna, Wasslavik Carina, Johansson Peter, Palmqvist Lars, Asp Jul |
|
V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease.
Journal of cellular biochemistry 2019 May . Asadzadeh-Aghdaei Hamid, Mashayekhi Kazem, Koushki Khadijeh, Azimzadeh Pedram, Rostami-Nejad Mohammad, Amani Davar, Chaleshi Vahid, Haftcheshmeh Saeed Mohammadian, Sahebkar Amirhossein, Zali Mohammad Re |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.
Journal of hepatology 2017 May . Poisson Johanne, Plessier Aurélie, Kiladjian Jean-Jacques, Turon Fanny, Cassinat Bruno, Andreoli Annalisa, De Raucourt Emmanuelle, Goria Odile, Zekrini Kamal, Bureau Christophe, Lorre Florence, Cervantes Francisco, Colomer Dolors, Durand François, Garcia-Pagan Juan-Carlos, Casadevall Nicole, Valla Dominique-Charles, Rautou Pierre-Emmanuel, Marzac Christophe, |
|
[Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance].
Zhongguo shi yan xue ye xue za zhi 2017 Feb 25 (1): 151-156. Tang Qin, Zhang Xiu-Wen, Xia Lei, Jiang Nai- |
|
[The development and comparative approbation of methods of increasing sensitivity of detection of mutation V617F in gene JAK2 by pyro-sequencing].
Klinicheskaia laboratornaia diagnostika 2017 Feb 62 (2): 125-8. Dunaeva E A, Mironov K O, Subbotina T N, Olkhovsky I A, Shipulin G |
|
Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2(V617F) mutations and laboratory findings: a meta-analysis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Saki N, Shirzad R, Rahim F, Saki Malehi |
|
[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].
Terapevticheskii arkhiv 2017 89 (7): 4-9. Melikyan A L, Subortseva I N, Sudarikov A B, Kovrigina A M, Gilyazitdinova E A, Kolosheinova T I, Abdullaev A O, Treglazova S |
|
Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2016 Sep . Rai Praveer, Kumar Pankaj, Mishra Swapnil, Aggarwal Rake |
|
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Oncotarget 2016 Jul . Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh |
|
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
|
Thrombotic risk correlates with mutational status in true-essential thrombocythemia.
European journal of clinical investigation 2016 Jun . Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi M |
|
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.
American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
|
Molecular biomarkers of thrombosis in myeloproliferative neoplasms.
Thrombosis research 2016 Apr 140 Suppl 1 S71-5. Barbui Tiziano, Falanga An |
|
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status.
Thrombosis research 2016 Apr 140 Suppl 1 S183. Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden P E J, Swieringa F, Ten Cate H, Heemskerk J W M, Rambaldi A, Falanga |
|
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.
Leukemia research 2016 Apr 46 18-25. Gugliotta Luigi, Iurlo Alessandra, Gugliotta Gabriele, Tieghi Alessia, Specchia Giorgina, Gaidano Gianluca, Scalzulli Potito R, Rumi Elisa, Dragani Alfredo, Martinelli Vincenzo, Santoro Cristina, Randi Maria Luigia, Tagariello Giuseppe, Candoni Anna, Cattaneo Daniele, Ricco Alessandra, Palmieri Raffaele, Liberati Marina A, Langella Maria, Rago Angela, Bergamaschi Micaela, Monari Paola, Miglio Rossella, Santoro Umberto, Cacciola Rossella, Rupoli Serena, Mastrullo Lucia, Musto Pellegrino, Mazzucconi Maria Gabriella, Vignetti Marco, Cortelezzi Agostino, Vianelli Nicola, Martino Bruno, Stefano Valerio De, Passamonti Francesco, Vannucchi Alessandro M, |
|
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.
Clinical lymphoma, myeloma & leukemia 2016 Feb . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Primary thrombophilia in Mexico: a single tertiary referral hospital experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016 Jan . Lacayo-Leñero Dennis, Hernández-Hernández Darinel, Valencia-Martínez Andrés, Barrales-Benítez Olga, Vargas-Ruiz Angel |
|
Specifics of the course and the clinical pictures of essential thrombocythemia depending on the JAK2V617F status of the patients.
Problemy radiatsiinoi medytsyny ta radiobiolohii 2015 Dec 20 399-413. Mishcheniuk O Y, Kostukevich O M, Dmytrenko I V, Klymenko S |
|
Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
|
Thrombophilia Profile in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis: A Study from Western India.
The Journal of the Association of Physicians of India 2015 Sep 63 (9): 32-5. Sawant Prabha, Vashishtha Chitranshu, Nasa Mukesh, Parikh Pathik, Patel Jignesh, Agasti Anan |
|
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Aug . Moussaoui S, Saussoy P, Ambroise J, Defour J P, Zouitene R, Sifi K, Abadi |
|
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Thrombosis and haemostasis 2015 Jul 114 (2): 245-57. Dennis J, Kassam I, Morange P-E, Trégouët D-A, Gagnon |
|
Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Jun 26 (4): 448-53. Kissova Jarmila, Ovesna Petra, Bulikova Alena, Zav?elova Ji?ina, Penka Mirosl |
|
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
|
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.
Turkish journal of haematology : official journal of Turkish Society of Haematology 2015 Apr . Yönal Ipek, Da?lar Aday Aynur, Akadam Teker Ba?ak, Ceylan Y?lmaz, Nalcac? Meliha, Yavuz Akif Selim, Sarg?n Fatma Den |
|
Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.
Mædica 2015 Mar 10 (1): 27-32. Tevet Mihaela, Ionescu Razvan, Dragan Cornel, Lupu Anca Roxa |
|
Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study.
Chinese medical journal 0 129 (15): 1778-1783. Sun Chao, Zhou Xin, Zou Zhi-Jian, Guo Hong-Feng, Li Jian-Yong, Qiao Ch |
|
Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 0 26 (1): 115-121. Prajs Iwona, Kuliczkowski Kazimie |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 08, 2021
- Content source: